Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Moury Construct operating income jumps 24% to EUR 22.52 million in H1 2026; revenue rises 18% to EUR 147.57 million

Moury Construct operating income jumps 24% to EUR 22.52 million in H1 2026; revenue rises 18% to EUR 147.57 million

BitgetBitget2026/09/29 16:15
  • Moury Construct posted first-half 2026 revenue up 18% to EUR 147.57 million.
  • Operating result climbed 24% to EUR 22.52 million, lifting net margin to 15.1% from 14.5% a year earlier.
  • Result for the period rose 15% to EUR 17.48 million, while financial result fell 73% to EUR 821,000.
  • Net cash totaled EUR 138.2 million at June 30, down from EUR 152.5 million at Dec. 31, 2025.
  • Board expects 2026 operating result growth; order book reached EUR 370 million at Aug. 31, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moury Construct SA published the original content used to generate this news brief on September 29, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials

Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.

智通财经•2026/10/10 06:21